To determine if latency antibiotic regimens including azithromycin versus erythromycin has an impact on latency period or rates of chorioamnionitis. STUDY DESIGN: : We conducted a prospective observational cohort study and followed all women receiving latency antibiotic treatment involving either azithromycin or erythromycin in the context of preterm premature rupture of membranes. Choice of regimen was determine by attending physician preference. The azithromycin group consisted of azithromycin 1g PO once and ampicillin 2g every 6 hours IV for 48 hours followed by 5 days of amoxicillin 250mg every 8 hours PO for 5 days. The erythromycin group consisted of erythromycin 250mg and ampicillin 2g every 6 hours IV for 48 hours followed by amoxicillin 250mg and erythromycin 500mg every 8 hours PO for 5 days. Primary outcomes were duration of latency period and delivery without development of chorioamnionitis. Patients were excluded if latency antibiotic regimen included combinations apart from those defined. Patients were excluded if final pathological analysis of placenta did not confirm chorioamnionitis. RESULTS: The study included 101 patients, with 47 receiving azithromycin regimen and 54 receiving erythromycin. No statistical difference was noted in latency period, cesarean delivery rate, or development of neonatal sepsis in either crude or adjusted analysis. When compared with the erythromycin regimen group, the azithromycin regimen group had lower rates of chorioamnionitis 27.9% (95% CI 25.1-31.3) versus 34.9% (95% CI 29.8-37.3), p ¼ 0.021. In crude analysis, compared to erythromycin regimen group, the azithromycin regimen group had lower risk of chorioamnionitis (RR 0.58, 95% CI 0.11-0.87, p ¼ 0.01). After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), and parity, this lower risk was consistently demonstrated (RR 0.43, p ¼ 0.045). CONCLUSION: This is the first prospective study to evaluate difference in latency antibiotic regiments including either azithromycin or erythromycin. Our study suggests that latency antibiotic regimens substituting azithromycin for erythromycin have a lower risk of chorioamnionitis and thus can be considered a superior option in the treatment of preterm premature rupture of membranes.
OBJECTIVE:
To determine if latency antibiotic regimens including azithromycin versus erythromycin has an impact on latency period or rates of chorioamnionitis. STUDY DESIGN: : We conducted a prospective observational cohort study and followed all women receiving latency antibiotic treatment involving either azithromycin or erythromycin in the context of preterm premature rupture of membranes. Choice of regimen was determine by attending physician preference. The azithromycin group consisted of azithromycin 1g PO once and ampicillin 2g every 6 hours IV for 48 hours followed by 5 days of amoxicillin 250mg every 8 hours PO for 5 days. The erythromycin group consisted of erythromycin 250mg and ampicillin 2g every 6 hours IV for 48 hours followed by amoxicillin 250mg and erythromycin 500mg every 8 hours PO for 5 days. Primary outcomes were duration of latency period and delivery without development of chorioamnionitis. Patients were excluded if latency antibiotic regimen included combinations apart from those defined. Patients were excluded if final pathological analysis of placenta did not confirm chorioamnionitis. RESULTS: The study included 101 patients, with 47 receiving azithromycin regimen and 54 receiving erythromycin. No statistical difference was noted in latency period, cesarean delivery rate, or development of neonatal sepsis in either crude or adjusted analysis. When compared with the erythromycin regimen group, the azithromycin regimen group had lower rates of chorioamnionitis 27.9% (95% CI 25.1-31.3) versus 34.9% (95% CI 29.8-37.3), p ¼ 0.021. In crude analysis, compared to erythromycin regimen group, the azithromycin regimen group had lower risk of chorioamnionitis (RR 0.58, 95% CI 0.11-0.87, p ¼ 0.01). After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), and parity, this lower risk was consistently demonstrated (RR 0.43, 95% CI 0.18-0.71, p ¼ 0.045). CONCLUSION: This is the first prospective study to evaluate difference in latency antibiotic regiments including either azithromycin or erythromycin. Our study suggests that latency antibiotic regimens substituting azithromycin for erythromycin have a lower risk of chorioamnionitis and thus can be considered a superior option in the treatment of preterm premature rupture of membranes. OBJECTIVE: Periodontal disease and dental abscesses are established risk factors for preterm labor. Embryological origins of respective teeth are through to influence the organ systems of their associated origin. This study seeks to evaluate if periodontal disease/dental abscesses of those teeth associated embryologically with the female reproductive organs, number 7-10 or 23-26, is associated with adverse labor outcomes as compared to other locations. STUDY DESIGN: We conducted a retrospective cohort study and reviewed medical charts and dental records on all women diagnosed with periodontal disease/dental abscesses in the third trimester of pregnancy at our academic institution and affiliated dental clinic. Inclusion criteria included pregnant women 18-55 years old diagnosed with dental abscess with adequate dental records, gestational age >34 weeks gestational age, and no other diagnosis leading to preterm labor. The primary outcome evaluated was the development of preterm labor with known periodontal disease/dental abscess in the third trimester. RESULTS: The study included 31 patients, 16 patients with periodontal disease/dental abscesses involving teeth number 7-10 or 23-26, and 15 with periodontal disease/dental abscesses of other locations. When compared with the teeth of other locations, periodontal disease/dental abscess involving teeth number 7-10 or 23-26 had higher incidence of preterm labor 15.1% (95% CI 11.3-19) versus 8.2% (95% CI 5.5-11.6), p ¼ 0.044. In crude analysis, compared with the teeth of other locations, periodontal disease/ dental abscess involving teeth number 7-10 or 23-26 had higher risk of preterm labor (RR 1.66, 95% CI 1.13-1.99, p ¼ 0.01). After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), type of previous cesarean scar (low transverse, classical, or unknown) and parity, this risk was consistently demonstrated (RR 1.31, 95% CI 1.08-1.55, p ¼ 0.05). CONCLUSION: Pregnant women in the third trimester with dental abscesses involving teeth numbers 7-10 or 23-26 have an increased Poster Session III 
